摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

rac-17-cyclopropylmethyl-7,14-seco-8-nor-morphin-6-en-3,14β-diol

中文名称
——
中文别名
——
英文名称
rac-17-cyclopropylmethyl-7,14-seco-8-nor-morphin-6-en-3,14β-diol
英文别名
6-allyl-3-cyclopropylmethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocine-8,11anti-diol;(1S,9R,13S)-10-(cyclopropylmethyl)-1-prop-2-enyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-triene-4,13-diol
<i>rac</i>-17-cyclopropylmethyl-7,14-seco-8-nor-morphin-6-en-3,14β-diol化学式
CAS
——
化学式
C19H25NO2
mdl
——
分子量
299.413
InChiKey
ZIMJEWWBYGDXTD-QRVBRYPASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.58
  • 拓扑面积:
    43.7
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    描述:
    rac-17-cyclopropylmethyl-7,14-seco-8-nor-morphin-6-en-3,14β-diol盐酸 作用下, 生成 rac-(6Ξ)-17-cyclopropylmethyl-6,14β-epoxy-7,14-seco-8-nor-morphinan-3-ol
    参考文献:
    名称:
    5-Allyl-9-oxobenzomorphans. 3. Potent narcotic antagonists and analgesics-antagonists in the series of substituted 2',9.beta.-dihydroxy-6,7-benzomorphans
    摘要:
    5-Allyl-2'-methoxy-2-methyl-9-oxo-6,7-benzomorphan methiodide (1) has been converted in a selective two-step process to the corresponding 9beta-hydroxy intermediates 4 and 6, which in turn were transformed via modified von Braun demethylation-acylation to the amides 11 and 21, respectively. These were reduced and demethylated to give a series of 5-allyl-2',9beta-dihydroxy-2-substituted 6,7-benzomorphans 13 and 23, some of which have been found to be highly potent narcotic antagonists and/or analgesics. The resolution of the most interesting compounds (23a and 23b) and pharmacological properties of the optical isomers are also described. Reduction of the double bond in 13 and 23 to give 14 and 24, with one exception, did not appreciably alter pharmacological profiles, while cyclization to the tetrahydrofuranobenzomorphans 25 substantially reduced the level of activities.
    DOI:
    10.1021/jm00215a012
点击查看最新优质反应信息

文献信息

  • 5-Allyl-9-oxobenzomorphans. 3. Potent narcotic antagonists and analgesics-antagonists in the series of substituted 2',9.beta.-dihydroxy-6,7-benzomorphans
    作者:Michel Saucier、Jean Paul Daris、Yvon Lambert、Ivo Monkovic、Anthony W. Pircio
    DOI:10.1021/jm00215a012
    日期:1977.5
    5-Allyl-2'-methoxy-2-methyl-9-oxo-6,7-benzomorphan methiodide (1) has been converted in a selective two-step process to the corresponding 9beta-hydroxy intermediates 4 and 6, which in turn were transformed via modified von Braun demethylation-acylation to the amides 11 and 21, respectively. These were reduced and demethylated to give a series of 5-allyl-2',9beta-dihydroxy-2-substituted 6,7-benzomorphans 13 and 23, some of which have been found to be highly potent narcotic antagonists and/or analgesics. The resolution of the most interesting compounds (23a and 23b) and pharmacological properties of the optical isomers are also described. Reduction of the double bond in 13 and 23 to give 14 and 24, with one exception, did not appreciably alter pharmacological profiles, while cyclization to the tetrahydrofuranobenzomorphans 25 substantially reduced the level of activities.
查看更多

同类化合物

非那佐辛 酮佐辛盐酸盐 酮佐辛 莫克索兴 苄卡镇痛新 脱氧-N-苄基去甲美他佐辛 美他佐辛 环佐辛 环丙止痛胺 格各佐辛 布马佐辛 化合物 T27086 乳酸,化合物与(2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-六氢-6,11-二甲基-3-(3-甲基丁-2-烯基)-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇(1:1) N-(3-氟丙基)-N-去甲美他唑新 6-乙氧基-2,2,4-三甲基-1,2-二氢喹啉 6,11-二甲基-3-丙基-1,2,3,4,5,6-六氢-2,6-亚甲基-3-苯并吖辛因 5-乙基-2'-羟基-2(N)-(3-甲基-2-丁烯基)-9-甲基-6,7-苯并吗吩烷 3-苄基-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 3-己基-6,11-二甲基-1,2,3,4,5,6-六氢-2,6-亚甲基-3-苯并吖辛因 3-(环戊基甲基)-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 3-(环丙基羰基)-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 3-(环丁基甲基)-6,11-二甲基-1,2,3,4,5,6-六氢-8-甲氧基-2,6-甲桥-3-苯并氮杂环辛四烯 2-羟基-丙酸3-(环丁基甲基)-6-乙基-1,2,3,4,5,6-六氢-11,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-基酯 2-丙烯酸,2-甲基-,聚合丁基2-丙烯酸酯,乙烯基苯,2-羟基乙基2-丙烯酸酯,甲基2-甲基-2-丙烯酸酯和噁丙环基甲基2-甲基-2-丙烯酸酯 10-(环丙基甲基)-1,13-二甲基-10-氮杂三环[7.3.1.02,7]十三-2,4,6-三烯-4-醇 1,2,3,4,5,6-六氢-6-乙基-3-甲基-(+-)-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-6,11-二甲基-3-(3-甲基丁-2-烯基)-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇盐酸盐 1,2,3,4,5,6-六氢-6,11-二甲基-3-(2-丙炔基)-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-3-环丁基甲基-6-乙基-1-甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-3-(环丙基甲基)-6,11-二甲基-8-甲氧基-2,6-甲桥-3-苯并氮杂环辛四烯 1,2,3,4,5,6-六氢-3-(氰基甲基)-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-3-(3,3-二氯-2-丙烯基)-6-乙基-11-甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 1,2,3,4,5,6-六氢-3-(3,3-二氯-2-丙烯基)-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 (2alpha,6alpha,11R*)-1,2,3,4,5,6-六氢-6,11-二甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-醇 (2S-(2a,6a,11R)-1,2,3,4,5,6-六氢-6,11-二甲基-3-(2-丙烯基)-2,6-亚甲基-3-苯并吗吩烷-8-醇盐酸盐 (-)-布马佐辛盐酸盐 (-)-去甲美他佐辛 (-)-N-丙烯基去甲变肾上腺素 盐酸盐 (-)-5,9alpha-二乙基-2'-羟基苯并吗吩烷 (+-)-(2alpha,6alpha,11R*)-苯硫代羧酸S-(1,2,3,4,5,6-六氢-3,6,11-三甲基-2,6-甲桥-3-苯并氮杂环辛四烯-8-基)酯(E)-2-丁烯二酸盐(1:1)水合物 (+)-环佐辛 (+)-喷他佐辛 (+/-)-3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-cis-6,11-dimethyl-2,6-methano-3-benzazocin-8-thiocarboxamide 8-carboxamidocyclazocine (+/-)-3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-cis-6,11-dimethyl-N-(4-dimethylaminophenyl)-2,6-methano-3-benzazocin-8-amine (+)-pentazocine 5,9-dimethyl-2'-hydroxy-6,7-benzomorphan (-)-cis-2-(3,3-dimethylallyl)-5,9α-dimethyl-2'-fluoro-6,7-benzomorphan (+)-cis-2-(3,3-dimethylallyl)-5,9α-dimethyl-2'-fluoro-6,7-benzomorphan (-)-2'-fluoro-5,9α-dimethyl-6,7-benzomorphan